Zhitong Finance App News, Baiyunshan (600332.SH) issued an announcement. Recently, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. (“Tianxin Pharmaceutical”), a holding subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration. Amikacin sulfate injection (2ml: 0.2g) (200,000 units) has passed the consistent evaluation of the quality and efficacy of generic drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.